Christopher J. Moreau
Chief Executive Officer and Director
Mr. Moreau is a seasoned business professional in the life sciences sector with a strong background in biotechnology research, business development and a deep expertise in the capital markets. Mr. Moreau was previously President & CEO and Director of a publicly traded company focused on the research and development of screening tests for prostate cancer, skin cholesterol and type 2 diabetes. He has raised in excess of $30 million from the capital markets and has over 30 years of senior management experience in private and publicly traded company environments.
Christopher Bryan, PhD
Vice President Research & Operations
Dr. Christopher Bryan graduated from the University of Toronto, with a PhD in organic chemistry and brings significant skills and experience to Algernon. His background as a scientist and senior manager includes the synthesis of hundreds of novel small molecules as potential therapeutic agents, the coordination of regional commercial teams and internal departments (i.e., marketing, R&D, manufacturing, sales and regulatory affairs) and the management of multiple strategic relationships including those involving key opinion leaders. He also has extensive experience in scientific writing, data analysis and literature review.
James Kinley, CPA, CA
Mr. Kinley is a Certified Prelesional Accountant (“COA CA”) with over 15 years of experience in building, leading and advising corporations through their daily operations as well as on complex restructurings, mergers, acquisitions, and capital markets transactions. He is also accomplished in structuring and negotiating favorable terms with commercial and investment banks. He was previously the CFO for Medicure Inc. (TSX-V: MPH), another Canadian publicly traded pharmaceutical company, a position he held for nearly 10 years.
Dr. Ahmad Khalil MD PhD
Chief Medical Officer
Dr. Khalil has extensive biopharmaceutical experience bringing drugs into clinical trials over the past 20 years, acting in the capacities of Medical Director, Medical Monitor, and Clinical Consultant for a variety of companies. He is a member of the Harvard Medical School Postgraduate Association, the Canadian Medical Association, the University of Montreal General Professor Syndicate, and the American Heart Association Professional Membership & Cardiovascular Science Councils.